An investigative report reveals that Big Pharma's lobbying might have been a key factor in today's opioid epidemic. (Photo: iStock)

An investigation by the Associated Press and the Center for Public Integrity sheds light on the political machinations that helped pave the way for America’s opioid addiction crisis.

Pharmaceutical interests spent $880 million on lobbying state and federal lawmakers and regulators over the past decade, the investigation found. In contrast, groups that were pushing for greater restrictions on opioids collectively spent only $4 million.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?

Jack Craver



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.